Chemerin-9, an analog of chemerin, has a higher affinity for CMKLR1 and functions as an anti-inflammatory regulator to inhibit the development of atherosclerosis, Alzheimer's disease, and pancreatogenic diabetes [22–24]. This evidence concerns the gene CMKLR1 and early-onset autosomal dominant Alzheimer disease.